Sign Up to like & get
recommendations!
0
Published in 2017 at "European Journal of Pharmaceutics and Biopharmaceutics"
DOI: 10.1016/j.ejpb.2017.01.018
Abstract: Background: Docetaxel is a cytostatic agent approved for treatment of non‐small cell lung cancer as well as other cancers. Although docetaxel is an effective cytostatic agent, its effectiveness in clinical practice is associated with a…
read more here.
Keywords:
calcium sulfate;
reduced systemic;
formulation;
intra tumoral ... See more keywords